Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Myotonic dystrophy is a genetic disorder affecting multiple systems.
• Cerebral involvement in myotonic dystrophy is not fully understood.
• Noninvasive neuroimaging can help elucidate brain changes.

Purpose of the Study:

• To identify cerebral metabolite abnormalities in myotonic dystrophy patients using proton magnetic resonance spectroscopy (PMRS).
• To correlate the degree of these cerebral abnormalities with the size of the cytosine-thymine-guanine (CTG) trinucleotide repeat expansion, a measure of genetic defect severity.

Main Methods:

• Compared 14 myotonic dystrophy patients with 24 healthy controls.
• Utilized proton magnetic resonance spectroscopy (PMRS) to measure cerebral metabolites.
• Quantified cytosine-thymine-guanine (CTG) trinucleotide repeat length in leukocytes.

Main Results:

• Patients showed elevated levels of myoinositol, total creatine, and choline-containing compounds compared to controls.
• Creatine and myoinositol levels correlated significantly with CTG repeat size, particularly in the temporoparietal region (r=0.76; P=.004).

Conclusions:

• Neurochemical alterations in myotonic dystrophy are proportional to CTG repeat size.
• Elevated myoinositol and creatine may indicate increased glial content.
• Elevated choline-containing compounds suggest glial proliferation and cell membrane abnormalities.
• PMRS is a valuable noninvasive tool for assessing brain biochemistry and neuropathological involvement in myotonic dystrophy.